Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for EXHI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
April 30, 2026 0.00
January 31, 2026 0.00
October 31, 2025 0.00
July 31, 2025 0.00
April 30, 2025 0.00
January 31, 2025 0.00
October 31, 2024 0.00
July 31, 2024 0.00
April 30, 2024 0.00
January 31, 2024
October 31, 2023 -0.145M
July 31, 2023 0.0187M
April 30, 2023 0.1263M
January 31, 2023
October 31, 2022 0.00
July 31, 2022 0.4494M
April 30, 2022 0.0006M
June 30, 2021
March 31, 2021
December 31, 2020
September 30, 2020
June 30, 2020
March 31, 2020
December 31, 2019
September 30, 2019
Date Value
June 30, 2019
March 31, 2019
December 31, 2018
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014
December 31, 2013
September 30, 2013
June 30, 2013

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Xcelerate, Inc. -0.052M
Vivos Therapeutics, Inc. 3.228M
Hinge Health, Inc. -30.48M
Anika Therapeutics, Inc. -0.701M
Enovis Corp. -50.56M